Comp Effectiveness Needed To Slow Spread Of New Technology – MedPAC
This article was originally published in The Gray Sheet
Executive Summary
Expanding federally funded comparative clinical effectiveness research is needed to slow use of costly but questionable new medical technology, the chairman of a congressional advisory group on Medicare told a House panel March 17
You may also be interested in...
Bill Would Have New Agency Set Medicare Reimbursement Rates
Legislation introduced by Sen. Jay Rockefeller, D-W.Va., would convert the Medicare Payment Advisory Commission into an executive branch agency responsible for determining payment rates for items and services furnished under Medicare
Bill Would Have New Agency Set Medicare Reimbursement Rates
Legislation introduced by Sen. Jay Rockefeller, D-W.Va., would convert the Medicare Payment Advisory Commission into an executive branch agency responsible for determining payment rates for items and services furnished under Medicare
Imaging Sector Favors Electronic Oversight Vs. Radiology Benefits Managers
The Medical Imaging & Technology Alliance says a new study supports its argument that appropriateness guidelines are better than prior authorization requirements for preventing unnecessary advanced imaging procedures